ITC Patent Complaint Filed on Reduced Folate Nutraceuticals
According to the International Trade Commission, a section 337 patent complaint on certain reduced folate nutraceutical products and L-methylfolate raw ingredients used therein was filed on behalf of South Alabama Medical Science Foundation, Merck & Cie, and Pamlab LLC on Sept. 10. The proposed respondents are:
Sign up for a free preview to unlock the rest of this article
Communications Daily is required reading for senior executives at top telecom corporations, law firms, lobbying organizations, associations and government agencies (including the FCC). Join them today!
- Gnosis Spa, Italy;
- Gnosis Bioresearch SA, Switzerland;
- Gnosis USA Inc., Doylestown, Pennsylvania; and
- Macoven Pharmaceuticals LLC, Magnolis, Texas.
(D/N 2912, Received 09/10/12)